The real opportunity is pill-form peptides that could hit big pharma’s most profitable franchises.

The 1964 Chevelle Malibu SS arrived just before Detroit’s horsepower race exploded, yet it quietly sketched the blueprint that later muscle cars would follow. Positioned between compact and full-size, ...

Veru Inc. has pivoted to focus on preventing lean mass reduction in patients using GLP-1 agonists, leveraging its lead asset, enobosarm. A Phase 2b trial showed that a 3mg dose of Enobosarm reduces ...